Department of Bioengineering

Subscribe to Department of Bioengineering feed
The future of biology. The future of engineering.
Updated: 2 hours 39 min ago

UC Berkeley scientists uncover neural mechanisms behind long-term memory

Thu, 07/10/2025 - 20:48
Researchers from Professor Michael Yartsev’s lab used wireless recording devices to track neural activity in Egyptian fruit bats, revealing new clues to how our long-term memories are formed. The study, published in Nature, was supported by grants from the Air Force Office of Scientific Research, the National Institute of Neurological Disorders and Stroke and the…
Categories: Science News

Keasling Named 2025 DOE/NAI Innovator of the Year

Fri, 06/27/2025 - 12:28
The Department of Energy and the National Academy of Inventors have honored Professor Jay Keasling with their 2025 Innovator of the Year Award, which goes to one DOE employee who has translated research into tangible impacts that have benefited society at large. Keasling is a pioneer in synthetic biology who leads a groundbreaking research program focused on engineering microorganisms to produce advanced biofuels and chemicals.
Categories: Science News

New Process Uses Microbes to Create Valuable Materials from Urine

Wed, 06/18/2025 - 12:39
A team led by BioE alumnus Yasuo Yoshikuni genetically modified yeast to create hydroxyapatite, a strong and lightweight material, from the elements present in urine. With lower production costs the material may now be practical for use in wastewater treatment, fertilizer manufacturing, building materials and plastic replacement.
Categories: Science News

Alumna startup Aluna acquired by Huma

Thu, 06/12/2025 - 11:20
Aluna, a company spun out of an undergraduate capstone project by alumna Charvi Shetty, has been acquired by Huma. Aluna developed an easy and fun remote monitoring system for respiratory diseases, which will now be able to reach patients in Huma's more than 150 U.S. health systems, serving over 500,000 people.
Categories: Science News

UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics

Sun, 06/08/2025 - 15:21
Professor Phil Messersmith and colleagues have launched HypO2Regen Therapeutics, a startup developing novel, disease-modifying therapeutics for chronic intractable inflammatory diseases, including the first cell-free stem cell treatment that induces true regeneration of damaged tissue. Their first effort takes aim at periodontitis, which affects over 300 million people worldwide.
Categories: Science News